MAXWELL BIOSYSTEMS

Founded in September 2016 as an ETH Zürich spin-off, MaxWell Biosystems is a technology leader providing instrumentation and solutions to boost scientific research and development in neurosciences, stem cell and tissue engineering, ophthalmology, and other fields involving electrogenic cells. MaxOne (single-well) and MaxTwo (multi-well) are easy-to-use systems that equip scientists with the ability to record electrical signals of neurons in in-vitro 2D and 3D models at network, cellular, and subcellular levels. MaxWell Biosystems' main goal is to be a trusted partner to all users and collaborators, for a greater cause, of advancing scientific breakthroughs and for achieving faster and more effective drug discovery, through our products, solutions, and expertise... MaxWell Biosystems AG provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery.

Also known as: MaxWell Biosystems AG

Primary location: Zurich Switzerland